G1 Therapeutics (GTHX) ROA US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -42.9% | -43.4% | -58.4% | -78.5% | -39.5% | -45.4% | ||
| Changes by years, y/y, % | -20pp | -1pp | -15pp | -20pp | +39pp | +11.4% | |||
G1 Therapeutics. ROA, %
G1 Therapeutics. ROA, changes, pp
G1 Therapeutics (GTHX) ROA US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| ROA, % | ? | -55.9% | -56.9% | -43.5% | -30.0% | -45.4% | -45.4% | |
| Changes by years, y/y, % | +38pp | +38pp | +38pp | +52pp | +11pp | |||
| Changes by quarters, q/q, % | +26pp | -1pp | +13pp | +14pp | -15pp | |||